Hanan Jafar
7
1
1
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Clinical and Radiographic Evaluation of Allogenic Dentin Grafts for Alveolar Ridge Preservation
Role: collaborator
Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis
Role: lead
Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis
Role: lead
Autologous Platelet Lysate in Corneal Epithelial Defects
Role: lead
The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer
Role: lead
Safety and Efficacy of Resticutis Compared to Platelet-Poor Plasma for Treating Diabetic Foot Ulcers
Role: lead
Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease
Role: lead
All 7 trials loaded